A global view on carbapenem-resistant Acinetobacter baumannii

Area of Science:

• Clinical Microbiology and Infectious Diseases
• Antimicrobial Resistance
• Global Health Epidemiology

Background:

• Carbapenem-resistant Acinetobacter baumannii (CRAB) poses a significant public health threat due to resistance to last-line antibiotics.
• Globally, CRAB epidemiology is often dominated by international clones with known resistance genes.
• However, local CRAB lineages with distinct characteristics may influence regional disease burden and treatment.

Purpose of the Study:

• To investigate the global diversity and epidemiology of carbapenem-resistant Acinetobacter baumannii (CRAB) isolates.
• To identify potential regional variations in CRAB lineages and their associated antimicrobial resistance profiles.
• To inform localized infection prevention and control strategies for CRAB.

Main Methods:

• Analysis of CRAB isolates from 114 hospitals across 47 countries, representing five world regions.
• Ensuring broad geographic representation to capture global epidemiological diversity.
• Characterization of resistance gene profiles within different geographic lineages.

Main Results:

• A distinct CRAB lineage was identified circulating in Latin America, differing from those found in other geographic regions.
• This Latin American lineage exhibited a unique antimicrobial resistance gene profile compared to global CRAB strains.
• The study highlights significant geographic variation in CRAB epidemiology and resistance mechanisms.

Conclusions:

• CRAB epidemiology is not uniform globally, with distinct local lineages posing unique challenges.
• The identification of a specific CRAB lineage in Latin America necessitates tailored infection prevention and control measures.
• Antimicrobial resistance in bacteria like CRAB will continue to evolve, demanding adaptive global and local healthcare strategies.